Related Experiment Video
Updated: Aug 5, 2026

Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality
Published on: May 5, 2022
Oxygen-enhanced assembloid-based vascularized intestinal-on-a-chip for radioprotective drug evaluation
Yuting Guo1,2,3,4, Meiling Fu1,2, Yuan Pang1,2,3
1Biomanufacturing Center, Department of Mechanical Engineering, Tsinghua University, Beijing, China.
Background:
The intestine plays essential roles in digestion, immunity, and metabolism, but is highly sensitive to ionizing radiation during cancer treatment or environmental exposure. Although three-dimensional intestinal models more accurately replicate tissue architecture than conventional monolayers, they are frequently limited by insufficient oxygen delivery, leading to hypoxia-associated functional impairment. Incorporating physiologically relevant oxygenation strategies remains a key challenge in advanced in vitro systems. This study aimed to establish a physiologically relevant in vitro intestinal model by improving oxygen mass transfer within three-dimensional tissue constructs, thereby enhancing structural organization and functional maturation, and subsequently applying the system to investigate radiation-related mechanisms and evaluate potential protective agents.
Methods:
Based on a microengineered 3D cell-assembly platform, intestinal epithelial cells, endothelial cells, and fibroblasts were spatially organized to form a structured intestinal tissue model. The composition of the cells was optimised to improve tissue uniformity and the function of the epithelial barrier. To alleviate hypoxia in the three-dimensional construct, an oxygen-permeable microwell system was employed to enhance oxygen diffusion and promote epithelial differentiation, as evidenced by the upregulation of Isx, Cyp3a5, and Tff3. A vascularized chip that recapitulated the in vivo intestinal-stromal-vascular interface was created by incorporating microvascular networks self-assembled from endothelial cells within a hydrogel matrix.
Results:
Following radiation exposure, the model exhibited characteristic symptoms of intestinal injury, such as decreased cell viability, impaired E-cadherin signaling, and compromised epithelial barrier integrity. Treatment with dimethyloxalylglycine (DMOG) mitigated these effects, confirming it's utility for assessing radioprotective drugs.
Conclusion:
This vascularized intestinal-on-a-chip model closely mimics the structure and function of the human intestinal microenvironment. It serves as a robust in vitro platform for studying radiation-induced intestinal injury and for screening candidate protective agents, offering valuable applications in radiation protection and regenerative medicine research.

